TAL1
T-cell acute lymphocytic leukemia protein 1
Also known as: bHLHa17, SCL, TAL1_HUMAN, TCL5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17542
- Gene
- TAL1
- Ensembl
- ENSG00000162367
- Chromosome
- 1
- Canonical length
- 331 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables several functions, including E-box binding activity; RNA polymerase II-specific DNA-binding transcription factor binding activity; and histone deacetylase binding activity. Involved in several processes, including myeloid cell differentiation; positive regulation of cellular component organization; and positive regulation of erythrocyte differentiation. Located in chromatin and nucleoplasm. Part of transcription regulator complex. Implicated in acute lymphoblastic leukemia. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
331 residues, UniProt reviewed canonical sequence.
>P17542|TAL1
1 MTERPPSEAA RSDPQLEGRD AAEASMAPPH LVLLNGVAKE TSRAAAAEPP VIELGARGGP
61 GGGPAGGGGA ARDLKGRDAA TAEARHRVPT TELCRPPGPA PAPAPASVTA ELPGDGRMVQ
121 LSPPALAAPA APGRALLYSL SQPLASLGSG FFGEPDAFPM FTTNNRVKRR PSPYEMEITD
181 GPHTKVVRRI FTNSRERWRQ QNVNGAFAEL RKLIPTHPPD KKLSKNEILR LAMKYINFLA
241 KLLNDQEEEG TQRAKTGKDP VVGAGGGGGG GGGGAPPDDL LQDVLSPNSS CGSSLDGAAS
301 PDSYTEEPAP KHTARSLHPA MLPAADGAGP RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TAL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 28 nTPM
- lung: 7.1 nTPM
- placenta: 6.5 nTPM
- adipose tissue: 6.4 nTPM
- spleen: 3.8 nTPM
- breast: 3.1 nTPM
Single-cell type
- platelets: 524 nCPM
- microglia: 159 nCPM
- megakaryocytes: 142 nCPM
- erythrocyte progenitors: 87 nCPM
- megakaryocyte-erythroid progenitors: 71 nCPM
- megakaryocyte progenitors: 71 nCPM
Immune cell
- basophil: 0.9 nTPM
- total PBMC: 0.6 nTPM
- neutrophil: 0.3 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- midbrain: 12 nTPM
- spinal cord: 12 nTPM
- pons: 12 nTPM
- white matter: 11 nTPM
- medulla oblongata: 11 nTPM
- thalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- astrocyte fate commitment
- basophil differentiation
- cell fate commitment
- definitive hemopoiesis
- embryonic hemopoiesis
- erythrocyte differentiation
- erythrocyte maturation
- hematopoietic stem cell differentiation
- hemopoiesis
- locomotory behavior
- megakaryocyte development
- megakaryocyte differentiation
- negative regulation of transcription by RNA polymerase II
- platelet formation
- positive regulation of cell division
- positive regulation of DNA-templated transcription
- positive regulation of erythrocyte differentiation
- positive regulation of mitotic cell cycle
- positive regulation of protein-containing complex assembly
- positive regulation of transcription by RNA polymerase II
- regulation of cell population proliferation
- regulation of somatic stem cell population maintenance
- regulation of transcription by RNA polymerase II
- spinal cord association neuron differentiation
- transcription by RNA polymerase II
- hemangioblast cell differentiation
- positive regulation of chromatin organization
- regulation of mast cell differentiation
Molecular functions
- chromatin binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- enzyme binding
- histone deacetylase binding
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TAL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TAL1 as an antibody target. Whether an autoantibody or antibody against TAL1 could matter depends on whether native TAL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TAL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TAL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...